Vitamin K Deficiency: Bone Health and Fractures

Most people think of vitamin K as the “clotting vitamin,” and that is exactly why its quieter, slower job tends to go unnoticed: vitamin K is also the switch that lets your bones lock calcium into place. The protein your skeleton uses to bind calcium — osteocalcin — cannot do its job until vitamin K activates it. When vitamin K runs low, a surprising amount of osteocalcin circulates in an inactive, undercarboxylated form, calcium is handled less efficiently, and over years the bone may become a little more fragile and a little more likely to fracture — all without a single dramatic symptom along the way. This page explains how a low vitamin K status (and especially low vitamin K2) is tied to bone strength and fracture risk, why the bone story is so easy to miss, who is most affected, and — honestly — how much we can and cannot say from the evidence.

Table of Contents

1. What Low Vitamin K Does to Bone (and Why You Feel Nothing)
2. The Mechanism: Osteocalcin, the Calcium “Velcro”
3. K1 vs K2: Why the Form Matters for Bone
4. What the Fracture Evidence Actually Shows
5. Honesty: Bone Loss Has Many Causes
6. When Low Vitamin K Is a Plausible Piece of the Puzzle
7. What Lowers Vitamin K Status
8. Getting Tested
9. Correcting Low Vitamin K Safely
10. When to Seek Care / Red Flags
11. Key Research Papers
12. Connections
13. Featured Videos

What Low Vitamin K Does to Bone (and Why You Feel Nothing)

Here is the uncomfortable truth about vitamin K and your skeleton: there is nothing to feel. Unlike the muscle cramps of low potassium or the numbness of low calcium, a slow decline in bone quality from chronically low vitamin K produces no ache, no warning twinge, and no visible sign. Bone is being quietly remodeled every day — old bone removed, new bone laid down — and vitamin K works in the background of that process. When it is in short supply, the new bone is built with less efficient calcium handling, but the change is measured in years, not days.

That silence is the whole problem. The first “symptom” of vitamin-K-related bone fragility, when it appears at all, is often the fracture itself — a wrist broken in a minor fall, a vertebra that quietly compresses and shows up as loss of height or a stooped posture, or a hip fracture after a stumble that should not have caused one. These are called fragility fractures: breaks that happen from a force a healthy skeleton would shrug off, such as a fall from standing height.

Because there is no felt warning, the people most affected — older adults, and especially postmenopausal women — usually have no idea anything is amiss until bone density testing, or a fracture, reveals it. This is why the bone role of vitamin K is best thought of not as a symptom you notice but as a risk you carry, modifiable over the long term through diet and overall bone care. It is worth being clear from the start: low vitamin K is one contributor among several, not a stand-alone disease, and the section on honesty below puts it in proper proportion.

Back to Table of Contents

The Mechanism: Osteocalcin, the Calcium “Velcro”

To understand why vitamin K matters to bone, you have to meet a protein called osteocalcin. Osteocalcin is made by your bone-building cells (osteoblasts) and is one of the most abundant proteins in the bone matrix. Its job is to grab onto calcium and help organize it into the mineral lattice that gives bone its hardness. But osteocalcin is born inert. It only becomes able to bind calcium after it is chemically modified in a step called carboxylation — and that step absolutely requires vitamin K.

Here is the chemistry, in plain terms. Osteocalcin (and a family of related proteins called Gla proteins) has special amino-acid sites that must be converted into calcium-grabbing “hooks” known as Gla residues (gamma-carboxyglutamate). The enzyme that installs those hooks — gamma-glutamyl carboxylase — cannot run without vitamin K as its essential cofactor. With enough vitamin K, osteocalcin is fully carboxylated, its calcium hooks are in place, and it can anchor calcium into bone. Without enough vitamin K, osteocalcin leaves the factory only partly finished — undercarboxylated osteocalcin (ucOC) — with too few working hooks to do its job well.

An analogy. Think of osteocalcin as strips of Velcro whose job is to hold calcium tiles onto the wall of your bone. Vitamin K is the machine that stamps the tiny hooks onto each Velcro strip. Plenty of vitamin K, and every strip comes out covered in hooks — the tiles stick firmly. Run the machine short on vitamin K, and the strips come out half-bald: they look like Velcro, but they barely grip, and tiles that should be locked down stay loosely attached. The wall (your bone) still gets built, but the calcium is held less securely.

The practical, measurable consequence is that when vitamin K is low, the proportion of osteocalcin circulating in the undercarboxylated form rises. That percentage of undercarboxylated osteocalcin is, in fact, one of the most sensitive indicators of vitamin K status in the body — more sensitive than measuring vitamin K in the blood directly. And in several studies, a higher level of undercarboxylated osteocalcin has been associated with lower bone density and a greater risk of hip fracture in older women, which is the thread that ties the biochemistry to the broken bone.

It is worth adding that the same vitamin-K-dependent carboxylation activates another Gla protein called matrix Gla protein, whose job is to keep calcium out of arteries. That is why vitamin K is described as helping put calcium “in the right place” — into bone and away from blood vessels — and it is covered on the vitamin K and arterial calcification page. For the bone story, osteocalcin is the protein that matters most.

Back to Table of Contents

K1 vs K2: Why the Form Matters for Bone

Vitamin K is not a single molecule. There are two main families, and the distinction matters a great deal for bone:

• Vitamin K1 (phylloquinone) — the form found in green leafy vegetables such as kale, spinach, collards, and broccoli. K1 is the dominant form in most Western diets and is the form your liver prefers for making clotting factors.
• Vitamin K2 (menaquinones, abbreviated MK-n) — a family found in fermented foods (notably natto, a fermented soybean dish very rich in the long-chain form MK-7), in some cheeses and animal foods, and made in small amounts by gut bacteria. The two most-studied members are MK-4 and MK-7.

Why does the difference matter for the skeleton? Two reasons. First, the body appears to direct K2 preferentially to tissues outside the liver — including bone and blood-vessel walls — whereas K1 is largely taken up by the liver for clotting. Second, the long-chain menaquinone MK-7 stays in the bloodstream far longer than K1 (a half-life of days rather than hours), giving it sustained access to bone cells. Those properties are why much of the bone and fracture research — particularly the studies done in Japan, where high natto intake makes K2 status easy to study — has focused on K2 rather than K1. The differences between the two K2 forms are explored further on the MK-7 vs MK-4 page.

This is also why “vitamin K deficiency and bone” is, in practice, mostly a conversation about K2 status. You can have a diet rich enough in leafy-green K1 to keep your clotting normal — so a standard clotting test looks fine — while still having relatively little K2 reaching your bones. That mismatch is part of why the bone effects are so easy to overlook: the test most clinicians run (clotting) is a poor mirror of the vitamin K your skeleton is getting.

Back to Table of Contents

What the Fracture Evidence Actually Shows

This is where it is important to be precise rather than enthusiastic. The evidence linking vitamin K to bone comes in a few layers, and they do not all point with the same strength.

Observational studies (low intake linked to more fractures). Large prospective cohorts have repeatedly found that people with lower dietary vitamin K intake tend to have more hip fractures. In the Nurses' Health Study, women in the lowest fifth of vitamin K intake had a meaningfully higher risk of hip fracture than those eating more, and women eating lettuce (a K1 source) at least once a day had a lower risk than those eating it rarely. The Framingham study found a similar association between low vitamin K intake and hip fracture in older men and women. These studies are consistent and biologically plausible — but they are associations, and people who eat plenty of leafy greens differ in many other healthy ways, so they cannot prove cause and effect on their own.

The bone-density puzzle. Curiously, those same intake studies often found no consistent relationship between vitamin K intake and bone mineral density (the number a DEXA scan reports). Booth and colleagues found vitamin K intake associated with hip-fracture risk but not with BMD. That dissociation is actually informative: it suggests vitamin K may influence bone quality — how well the existing mineral is organized and held — more than bone quantity, which is what density measures. A bone can have a normal density number and still be of poorer quality.

Randomized trials (the harder test). Trials that actually give people vitamin K are more mixed. The strongest fracture signals have come from Japan using high-dose MK-4 (menatetrenone, 45 mg/day, a pharmaceutical dose) in women with osteoporosis: Shiraki's trial reported fewer new vertebral fractures and better-sustained spine bone density versus control. A three-year trial of low-dose MK-7 (180 µg/day) in healthy postmenopausal women (Knapen 2013) found it reduced age-related bone loss at the spine and hip and improved bone strength indices. But a 2006 meta-analysis (Cockayne) that pooled the trials concluded the fracture-reduction signal, while present, was driven largely by the Japanese MK-4 studies and called for caution, and some Western trials using K1 found benefits to bone-turnover markers without a clear fracture reduction.

The honest bottom line. Low vitamin K status is associated with weaker, more fracture-prone bone, and there is a clear, well-understood mechanism (osteocalcin) to explain why. High-dose K2 (MK-4) is an approved osteoporosis treatment in Japan. But vitamin K is not, on current evidence, a stand-alone fracture cure, and the trial results — especially outside high-dose Japanese protocols — are not uniform. The most defensible reading is that adequate vitamin K is one supportive piece of overall bone health, alongside the far more established roles of calcium, vitamin D, protein, and weight-bearing activity.

Back to Table of Contents

Honesty: Bone Loss Has Many Causes

It would be misleading to read this page and conclude that fragile bones mean “I must be low in vitamin K.” Osteoporosis and fragility fractures are multifactorial, and vitamin K is one of the less dominant factors. The major drivers of bone loss include:

• Estrogen loss at menopause — the single largest accelerator of bone loss in women; bone density can drop sharply in the years right after menopause regardless of vitamin K.
• Aging itself — bone formation slows and bone removal continues with age in both sexes.
• Low calcium and low vitamin D — the raw material for mineral and the hormone that lets you absorb it; deficiency in either is far more established as a fracture cause than low vitamin K. (See hypocalcemia and bone loss.)
• Glucocorticoid (steroid) medication — long-term prednisone and similar drugs are a leading cause of secondary osteoporosis.
• Smoking, heavy alcohol use, low body weight, and physical inactivity — each independently weakens bone.
• Other medical causes — overactive thyroid or parathyroid, early menopause, low testosterone in men, certain cancers, and malabsorptive gut disease.

So vitamin K belongs on the list, but well down it. A person who breaks a wrist in a fall is far more likely to be dealing with age- and estrogen-related bone loss and a calcium/vitamin-D shortfall than with isolated vitamin K deficiency. The right frame is: optimize the big levers first (calcium, vitamin D, exercise, not smoking, treating the underlying medical cause), and treat adequate vitamin K as a sensible, low-risk addition — not as the explanation for a fracture.

Back to Table of Contents

When Low Vitamin K Is a Plausible Piece of the Puzzle

Although low vitamin K rarely acts alone, there are situations where it is a more reasonable thing to consider as a contributor to poor bone health:

• Long-standing fat malabsorption. Vitamin K is fat-soluble, so conditions that impair fat absorption can lower it. People with celiac disease, Crohn's disease, chronic pancreatitis, cystic fibrosis, or cholestatic liver disease, or those who have had bariatric or bowel surgery, can run genuinely low on vitamin K (and on vitamins A, D, and E with it).
• Very low intake of greens and fermented/animal foods. Someone whose diet contains almost no leafy greens and essentially no K2 sources may have a low overall status, especially if combined with the points above.
• Concurrent low calcium or low vitamin D. Vitamin K does not work in isolation; its bone benefit depends on there being calcium to bind and vitamin D to absorb it. A multi-nutrient shortfall is more plausible (and more correctable) than a vitamin-K-only problem.
• Documented high undercarboxylated osteocalcin. In a research or specialist setting, a high percentage of undercarboxylated osteocalcin is the most direct sign that bone is not getting enough vitamin K.

Even in these situations, the correct response is to look at the whole bone picture — not to fixate on vitamin K. For the other ways low vitamin K shows up, see the sibling pages on bleeding and easy bruising and newborn bleeding (VKDB), which describe the far more rapid and dramatic clotting consequences of true deficiency.

Back to Table of Contents

What Lowers Vitamin K Status

A genuinely low vitamin K status in adults is uncommon from diet alone, because K1 is plentiful in greens and gut bacteria contribute some. When it does occur, the usual reasons are:

• Fat malabsorption — as above, the leading cause of true adult deficiency. Because vitamin K rides into the body on dietary fat, anything that blocks fat absorption blocks vitamin K.
• Liver and biliary disease — the liver needs vitamin K to make clotting factors, and bile is needed to absorb it; cholestatic liver disease impairs both.
• Prolonged antibiotics — broad-spectrum antibiotics can knock down the gut bacteria that contribute some K2, occasionally tipping a marginal person into deficiency, particularly if they are also eating poorly.
• Vitamin K antagonist anticoagulants (warfarin). This deserves special emphasis. Warfarin works by deliberately blocking vitamin K recycling to thin the blood. A predictable side effect of long-term warfarin is that osteocalcin and other bone Gla proteins are also left undercarboxylated, and some studies have linked long-term warfarin use to lower bone density and higher fracture risk. This does not mean people on warfarin should add vitamin K — the opposite is true. Extra vitamin K interferes with warfarin and can be dangerous; intake should be kept consistent, and any change discussed with the prescriber. (The newer direct oral anticoagulants do not work through vitamin K and do not carry this particular concern.)
• Very low-fat diets or poor overall intake — chronic undernutrition, or a diet nearly devoid of greens and fats, can lower status over time.

Back to Table of Contents

Getting Tested

There is no single, simple, widely available blood test that neatly reports “your bone vitamin K status.” This is one of the practical frustrations of the topic. What clinicians actually use depends on the question being asked:

• Clotting tests (PT/INR). The coagulation panel — prothrombin time and INR — is the standard, readily available marker of vitamin K function, but it reflects the liver/clotting pool of vitamin K, which is the last to fall. A normal INR does not rule out a low bone vitamin K status. It is mainly useful for detecting the more severe deficiency that threatens bleeding, covered on the bleeding page.
• Undercarboxylated osteocalcin (ucOC), or the ratio of undercarboxylated to total osteocalcin. This is the most direct marker of how much vitamin K is reaching bone, and a high level signals a relative bone vitamin K shortfall. It is used heavily in research and available through specialist labs, but it is not a routine test in most clinics.
• Bone mineral density (DEXA). If the real concern is fracture risk, the practical test is a DEXA scan to measure bone density and a clinical fracture-risk assessment — not a vitamin K level. This tells you whether bone is actually thin, which is what matters.
• Supporting nutrients. Because the bigger bone levers are calcium and vitamin D, a vitamin D (25-OH) test and a calcium level (on a comprehensive metabolic panel) are usually more informative for someone worried about bone health than chasing a vitamin K number.

The honest summary: for bone, the useful workup is a DEXA plus calcium and vitamin D, with vitamin K considered through diet and risk factors rather than a routine blood test.

Back to Table of Contents

Correcting Low Vitamin K Safely

For the great majority of people, supporting bone vitamin K is a food-first, low-drama affair.

• Food first. A daily serving or two of green leafy vegetables — kale, spinach, collards, Swiss chard, broccoli — easily covers vitamin K1. Because vitamin K is fat-soluble, eating greens with a little fat (olive oil, butter, nuts) improves absorption. For K2, fermented foods such as natto are by far the richest source; cheeses, egg yolks, and animal foods contribute smaller amounts. See the vitamin K food sources page for specifics.
• Adequate Intake (AI) targets. The U.S. Adequate Intake for vitamin K is about 120 µg/day for adult men and 90 µg/day for adult women — amounts a modest helping of greens meets easily. There is no separate official requirement for K2.
• Supplements, where they fit. The bone trials used either pharmaceutical high-dose MK-4 (45 mg/day, a prescription-level dose used in Japan for osteoporosis) or low-dose MK-7 (around 90–180 µg/day) in supplements. Over-the-counter K2 (MK-7) is generally considered safe for most people and is sometimes paired with vitamin D, but it should be viewed as an adjunct to the established bone basics, not a replacement for them.
• The non-negotiable warfarin caution. If you take warfarin (Coumadin) or another vitamin K antagonist, do not start a vitamin K supplement or sharply change your intake of greens without talking to the clinician who manages your anticoagulation. Vitamin K directly opposes warfarin and can throw off the INR in either direction. The goal on warfarin is steady, consistent vitamin K intake, not avoidance and not loading.
• Treat the bigger levers too. Vitamin K works best as part of a complete bone plan: enough calcium and vitamin D, sufficient protein, weight-bearing and resistance exercise, not smoking, moderating alcohol, and treating any underlying condition driving bone loss. For the deeper bone biology of K2 specifically, see the vitamin K2 and bone health page.

A reassuring point on safety: vitamin K1 and K2 from food and ordinary supplements have very low toxicity, and there is no established upper limit for them — the body handles excess well. (The synthetic form K3, menadione, is a different story and is not used as a supplement.) The real safety issue is not too much vitamin K in healthy people; it is the interaction with warfarin.

Back to Table of Contents

When to Seek Care / Red Flags

Because vitamin-K-related bone change is silent, the red flags are really the warning signs of a fracture or significant bone loss — situations that warrant prompt medical attention regardless of the cause:

• Sudden, severe back pain — especially in an older adult, and especially after a minor strain, bend, or fall. This can signal a vertebral compression fracture and should be evaluated.
• Noticeable loss of height or a new stooped (hunched) posture. Losing more than an inch or two of height, or developing a rounded upper back, can mean one or more spinal bones have quietly collapsed.
• A broken bone from a minor fall — a wrist, hip, or other fracture after a fall from standing height or less is a fragility fracture and is a strong signal to assess bone health and fracture risk.
• Hip pain or inability to bear weight after a fall. A suspected hip fracture is an emergency — seek care immediately.
• Easy bruising, frequent nosebleeds, or bleeding gums — these point to the clotting side of vitamin K and, if new and unexplained, should be checked promptly (see the bleeding and easy bruising page).

None of these prove a vitamin K problem — they prove a bone (or bleeding) problem that needs proper evaluation. Anyone over about 50 with a fragility fracture, or with the risk factors above, deserves a bone-density assessment and a review of all the contributing factors, of which vitamin K is only one.

Back to Table of Contents

Key Research Papers

1. Cockayne S, Adamson J, Lanham-New S, et al. (2006). Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Archives of Internal Medicine;166(12):1256-1261. — DOI: 10.1001/archinte.166.12.1256
2. Shiraki M, Shiraki Y, Aoki C, Miura M (2000). Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Journal of Bone and Mineral Research;15(3):515-521. — DOI: 10.1359/jbmr.2000.15.3.515
3. Knapen MHJ, Drummen NE, Smit E, Vermeer C, Theuwissen E (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International;24(9):2499-2507. — DOI: 10.1007/s00198-013-2325-6
4. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA (1999). Vitamin K intake and hip fractures in women: a prospective study. The American Journal of Clinical Nutrition;69(1):74-79. — DOI: 10.1093/ajcn/69.1.74
5. Booth SL, Tucker KL, Chen H, et al. (2000). Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. The American Journal of Clinical Nutrition;71(5):1201-1208. — DOI: 10.1093/ajcn/71.5.1201
6. Booth SL, Broe KE, Gagnon DR, et al. (2003). Vitamin K intake and bone mineral density in women and men. The American Journal of Clinical Nutrition;77(2):512-516. — DOI: 10.1093/ajcn/77.2.512
7. Booth SL, Centi A, Smith SR, Gundberg C (2013). The role of osteocalcin in human glucose metabolism: marker or mediator? Nature Reviews Endocrinology;9(1):43-55. — PubMed
8. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993). Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. Journal of Clinical Investigation;91(4):1769-1774. — PubMed
9. Vermeer C (2012). Vitamin K: the effect on health beyond coagulation — an overview. Food & Nutrition Research;56:5329. — PubMed
10. Palermo A, Tuccinardi D, D'Onofrio L, et al. (2017). Vitamin K and osteoporosis: myth or reality? Metabolism;70:57-71. — PubMed
11. Holick MF (2007). Vitamin D deficiency. New England Journal of Medicine;357(3):266-281. — DOI: 10.1056/NEJMra070553

PubMed Topic Searches

• PubMed — Vitamin K2 (menaquinone), bone density, and fracture
• PubMed — Undercarboxylated osteocalcin and hip fracture risk
• PubMed — MK-7 and postmenopausal bone loss
• PubMed — Warfarin, bone density, and fracture risk
• PubMed — Phylloquinone/menaquinone and osteoporosis (meta-analyses)

Back to Table of Contents

Connections

• Vitamin K Overview
• Vitamin K Deficiency: Bleeding & Easy Bruising
• Vitamin K Deficiency: Newborn Bleeding (VKDB)
• Vitamin K2 and Bone Health
• MK-7 vs MK-4
• Vitamin K2 and Arterial Calcification
• Vitamin K Food Sources
• Osteoporosis
• Calcium
• Hypocalcemia and Bone Loss
• Magnesium
• Vitamin D (25-OH) Test
• Comprehensive Metabolic Panel
• Coagulation Panel
• Natto
• Kale

Back to Table of Contents

×

Featured Videos